Benefit of Elevation of HDL-C on Cardiovascular Outcomes in Women

NCT00590629 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Niaspan

Sponsor

Cedars-Sinai Medical Center

Collaborators

[object Object]
[object Object]